See on Scoop.it – Health and Inhumanity
Ebola vaccine gold rush: Tekmira investors need a full-blown pandemic to really cash in
Dave Cottrell’s insight:
“Over 28 million shares of Tekmira stock changed hands last Friday in a flurry of buying activity. But have all these investors really thought about what would be necessary for Tekmira to earn a profit on its research?
Essentially, Tekmira only becomes profitable if there’s an exploding Ebola pandemic that begins killing people en masse, thereby forcing world governments to purchase and stockpile the vaccine.”